Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
Public ClinicalTrials.gov record NCT06856577. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Masked, Active-Comparator-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration (ARTEMIS)
Study identification
- NCT ID
- NCT06856577
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Adverum Biotechnologies, Inc.
- Industry
- Enrollment
- 284 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2025
- Primary completion
- Dec 21, 2026
- Completion
- Nov 22, 2030
- Last update posted
- Nov 17, 2025
2025 – 2030
United States locations
- U.S. sites
- 23
- U.S. states
- 6
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Adverum Clinical Site 223 | Gilbert | Arizona | 85297 | Recruiting |
| Adverum Clinical Site 178 | Phoenix | Arizona | 85021 | Recruiting |
| Adverum Clinical Site 126 | Phoenix | Arizona | 85053 | Recruiting |
| Adverum Clinical Site 229 | Scottsdale | Arizona | 85255 | Recruiting |
| Adverum Clinical Site 159 | Tucson | Arizona | 85704 | Recruiting |
| Adverum Clinical Site 198 | Springdale | Arkansas | 72764 | Recruiting |
| Adverum Clinical Site 109 | Bakersfield | California | 93309 | Recruiting |
| Adverum Clinical Site 100 | Beverly Hills | California | 90211 | Recruiting |
| Adverum Clinical Site 201 | Campbell | California | 95008 | Recruiting |
| Adverum Clinical Site 172 | Encino | California | 91436 | Recruiting |
| Adverum Clinical Site 169 | Fullerton | California | 92835 | Recruiting |
| Adverum Clinical Site 224 | Huntington Beach | California | 92647 | Recruiting |
| Adverum Clinical Site 215 | Redlands | California | 92374 | Recruiting |
| Adverum Clinical Site 164 | Riverside | California | 92505 | Recruiting |
| Adverum Clinical Site 140 | Sacramento | California | 95825 | Recruiting |
| Adverum Clinical Site 212 | Sacramento | California | 95841 | Recruiting |
| Adverum Clinical Site 175 | Santa Barbara | California | 93103 | Recruiting |
| Adverum Clinical Site 202 | Torrance | California | 90503 | Recruiting |
| Adverum Clinical Site 189 | Walnut Creek | California | 94598 | Recruiting |
| Adverum Clinical Site 200 | Denver | Colorado | 80222 | Recruiting |
| Adverum Clinical Site 116 | Lakewood | Colorado | 80228 | Recruiting |
| Adverum Clinical Site 165 | Waterford | Connecticut | 06385 | Recruiting |
| Adverum Clinical Site 184 | Deerfield Beach | Florida | 33064 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06856577, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06856577 live on ClinicalTrials.gov.